Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year

finance.yahoo.com/news/novo-nordisks-ceo-ozempic-makers-133200885.html

In This Article:
Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for the blockbuster drugs Ozempic and Wegovy, the company said Friday.
The move comes after Novo Nordisk’s share price fell 50%…

This story appeared on finance.yahoo.com, 2025-05-16 13:45:00.
The Entire Business World on a Single Page. Free to Use →